申请人:AbbVie Inc.
公开号:US10160748B2
公开(公告)日:2018-12-25
The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.
本公开提供了吲唑酮化合物、药学上可接受的盐、原药、生物活性代谢物、立体异构体和异构体,其中变量在本文中定义。本公开的化合物可用于治疗免疫学和肿瘤学疾病。